Cancer Chemotherapy and Pharmacology

, Volume 68, Issue 1, pp 147–156

Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis

  • Kurt Van der Speeten
  • O. Anthony Stuart
  • David Chang
  • Haile Mahteme
  • Paul H. Sugarbaker
Original Article

DOI: 10.1007/s00280-010-1460-4

Cite this article as:
Van der Speeten, K., Stuart, O.A., Chang, D. et al. Cancer Chemother Pharmacol (2011) 68: 147. doi:10.1007/s00280-010-1460-4



Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are a combined treatment modality considered for selected patients with peritoneal carcinomatosis from colorectal and appendiceal cancer. Mitomycin C is a drug often used in this clinical setting. The surgical and clinical factors that may influence the pharmacokinetics of hyperthermic intraperitoneal chemotherapy should be further elucidated.

Materials and methods

The patients included were 145 who had colorectal or appendiceal carcinomatosis resected using cytoreductive surgery prior to treatment with hyperthermic intraperitoneal chemotherapy with mitomycin C as part of a multidrug regimen. The effect of clinical and surgical factors on drug distribution after single intraperitoneal bolus administration with mitomycin C was determined.


The pharmacokinetics of 145 patients treated with intraperitoneal mitomycin C showed a 27 times greater exposure to peritoneal surfaces when compared to plasma. At 90 min, 29% of the drug remained in the chemotherapy solution, 62% was retained in the body, and 9% was excreted in the urine. The extent of peritonectomy increased the clearance of mitomycin C from the peritoneal space (p = 0.051). A major resection of visceral peritoneal surface and a contracted peritoneal space reduced drug clearance. A contracted peritoneal space significantly reduced (p = 0.0001) drug concentrations in the plasma.


Surgical and clinical factors may require modifications of drug dose or timing of chemotherapy administration. A large visceral resection and a contracted peritoneal space caused a reduced mitomycin C clearance. Total diffusion surface is an important determinant of mitomycin C pharmacokinetics.


Cytoreductive surgeryHyperthermic intraperitoneal chemotherapy (HIPEC)Mitomycin CIntraperitoneal chemotherapyAppendix cancerColorectal cancerChemotherapy pharmacokinetics

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Kurt Van der Speeten
    • 1
  • O. Anthony Stuart
    • 2
  • David Chang
    • 3
  • Haile Mahteme
    • 4
  • Paul H. Sugarbaker
    • 2
  1. 1.Department of Surgical OncologyZiekenhuis Oost-LimburgGenkBelgium
  2. 2.Washington Cancer InstituteWashington Hospital CenterWashingtonUSA
  3. 3.WestatRockvilleUSA
  4. 4.Department of Surgical SciencesAkademiska SjukhusetUppsalaSweden